跳至主要内容
临床试验/EUCTR2011-005441-13-DE
EUCTR2011-005441-13-DE进行中(未招募)1 期

Evaluation of efficacy and safety of autologous MSCs combined to biomaterials to enhance bone healing in patients with delayed consolidation after long bone fracture requiring graft apposition or alternative orthobiologics. - REBORNE - ORthoCT1

INSERM0 个研究点目标入组 30 人开始时间: 2012年5月18日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
INSERM
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - age 18 to 65 both sexes
  • - traumatic isolated closed or open Gustilo I and II humerus, tibial or femur diaphyseal or metaphysodiaphyseal fracture status delayed union or non union
  • - at least 3 months from acute fracture
  • - able to provide informed consent, and signed informed consent
  • - patients (by themselves) should have medical health care coverage to be included in a research study
  • - able to understand and accept the study constraints
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control
  • - participation in another therapeutic trial previous 3 months
  • - delayed union or non-union related to iatrogeny
  • - segmental bone loss requiring therapy
  • - vascular or neural injury
  • - impossibility to meet appointments for the follow up
  • - other fractures causing interference with weight bearing
  • - infection
  • viceral injuries of diseases interfering with callus formation
  • - history of bone harvesting on iliac crest contraindicating bone-marriw aspiration
  • - corticoid or immunosuppressive therapy more than one week in the 3 mionths prior ti study inclusion
  • - history of prior concurrent diagnosis of HIV, Hepatitis B or C infection
  • - insulin dependent diabetes
  • - autoimmune inflammatory disease
  • - current treatment by bisphonate or stopped in the 3 months prior to stydy inclusion
  • - subject legally protected, under legal guardianship, deprived of their liberty by judicial or administrative decision, subject of psychiatric care, or admission a health facility.

研究者

发起方
INSERM

相似试验